Our founders, Drs. Robert Broyles and Robert Floyd, discovered that a safe plant growth factor, EdX-17, has the potential to effectively induce expression of fetal hemoglobin (HbF) to levels that prevent the manifestations of sickle cell disease, ameliorate many forms of its sister disease beta-thalassemia, and block the chronic phase of malaria.
Proof-of-Concept studies have demonstrated that EdX-17 functions to enhance HbF through activation of ferritin heavy chain (FtH), a safe, stress response factor that is found naturally in both plants and animals.
Developing Cures for Global Diseases
755 Research Pkwy Ste 452
Oklahoma City, OK 73104